Fentanyl sequestration in lungs during cardiopulmonary bypass.

Area of Science:

• Anesthesiology
• Pharmacology
• Cardiovascular Surgery

Background:

• Fentanyl is commonly used for anesthesia during cardiac surgery.
• Cardiopulmonary bypass (CPB) alters physiological conditions, potentially affecting drug pharmacokinetics.
• Understanding fentanyl behavior during CPB is crucial for optimizing anesthetic management.

Purpose of the Study:

• To investigate serum fentanyl concentrations during cardiopulmonary bypass.
• To correlate fentanyl levels with physiological changes during cardiac surgery.
• To determine fentanyl distribution between pulmonary and systemic circulation during CPB.

Main Methods:

• Serum fentanyl concentrations were measured at multiple time points: pre-bypass, during bypass, and post-bypass.
• Physiological parameters including total protein, albumin, hematocrit, pH, and PCO2 were monitored.
• Simultaneous fentanyl concentrations were measured in pulmonary artery and radial artery during CPB.

Main Results:

• Serum fentanyl, total protein, albumin, and hematocrit decreased upon initiation of bypass.
• No significant changes in PCO2 or pH were observed during the study period.
• Pulmonary artery fentanyl concentrations were higher than radial artery concentrations during CPB, suggesting lung sequestration.
• Radial artery concentrations increased, and pulmonary artery concentrations decreased upon restoration of lung ventilation and perfusion.

Conclusions:

• Fentanyl undergoes sequestration in the lungs during cardiopulmonary bypass.
• Changes in physiological parameters like protein and hematocrit occur during CPB.
• These findings highlight the dynamic behavior of fentanyl during cardiac surgery and CPB, impacting drug delivery and efficacy.